ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 38831455

Targeting FGFR for cancer therapy.

Zhang P and 6 others. J Hematol Oncol, 2024. Cited by 101 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Targeting FGFR for cancer therapy. Papers, record 38831455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38831455

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting FGFR for cancer therapy.
PubMed
Journal
J Hematol Oncol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
13.61, provisional
iCite
Revised in PubMed
2024-11-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang PPei
2Yue LLin
3Leng QQingQing
4Chang CChen
5Gan CCailing
6Ye TTinghong
7Cao DDan

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Receptors, Fibroblast Growth FactorMajor topic
Signal TransductionMajor topic
Humans
Antineoplastic Agents
Molecular Targeted Therapy
Protein Kinase Inhibitors
Animals

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZYJC210161·3·5 project for disciplines of excellence-Clinical Research Incubation ProjectPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References231

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133,268,819Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance.Br J Cancer2021https://conductscience.org/library/papers/33268819PubMed
218,381,441FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival.Cancer Res2008https://conductscience.org/library/papers/18381441PubMed
311,031,111Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors.Genomics2000https://conductscience.org/library/papers/11031111PubMed
419,215,789Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma.Cancer Genet Cytogenet2009https://conductscience.org/library/papers/19215789PubMed
528,781,254[Fibroblast growth factors and their effects in pancreas organogenesis].Biomed Khim2017https://conductscience.org/library/papers/28781254PubMed
631,514,441Targeting Autophagy by MPT0L145, a Highly Potent PIK3C3 Inhibitor, Provides Synergistic Interaction to Targeted or Chemotherapeutic Agents in Cancer Cells.Cancers (Basel)2019https://conductscience.org/library/papers/31514441PubMed
735,544,727Progression-Free Survival in Patients With Cholangiocarcinoma With or Without FGF/FGFR Alterations: A FIGHT-202 Post Hoc Analysis of Prior Systemic Therapy Response.JCO Precis Oncol2022https://conductscience.org/library/papers/35544727PubMed
822,837,387Transforming fusions of FGFR and TACC genes in human glioblastoma.Science2012https://conductscience.org/library/papers/22837387PubMed
915,475,116Evolution of the Fgf and Fgfr gene families.Trends Genet2004https://conductscience.org/library/papers/15475116PubMed
1033,710,807Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases.Cancer Biol Med2021https://conductscience.org/library/papers/33710807PubMed

1 to 10 of 231

See all 231 references

Cited by71

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
42,977,970FGFBPs in health and tumors: emerging prognostic biomarkers and therapeutic implications.Biomark Res2026https://conductscience.org/library/papers/42977970PubMed
42,824,816FGFR signaling and apoptotic regulation in cancer: links to immune evasion, therapeutic resistance, and treatment re-engagement.Front Immunol2026https://conductscience.org/library/papers/42824816PubMed
42,736,558Spatial ecotype in tumor immune exclusion: from spatial architecture to therapeutic strategies.Mol Cancer2026https://conductscience.org/library/papers/42736558PubMed
42,702,389[Advances in intravesical therapy for non-muscle-invasive bladder cancer].Zhong Nan Da Xue Xue Bao Yi Xue Ban2026https://conductscience.org/library/papers/42702389PubMed
42,633,326Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.MedComm (2020)2026https://conductscience.org/library/papers/42633326PubMed
42,621,139The role of FGFR signaling in SCLC and NSCLC: Current insights and therapeutic perspectives.iScience2026https://conductscience.org/library/papers/42621139PubMed
42,524,362Efficacy of Pazopanib for a Patient with FGFR1-Amplified Breast Cancer: A Case Report.Case Rep Oncol2026https://conductscience.org/library/papers/42524362PubMed
42,510,988Mutational Landscape of FGFR4 Across Malignancies: A Cross-Cancer Analysis of the AACR Project GENIE Database.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42510988PubMed
42,473,650Bicaudal‑C1 in Cancer: Molecular Mechanisms and Therapeutic Strategies Integrating Chinese and Western Medicine.Drug Des Devel Ther2026https://conductscience.org/library/papers/42473650PubMed
42,383,990Blockade of FGFR1 Trafficking to the Cell Surface Results in the Partial Mistargeting of the Receptor to Peroxisomes.FASEB J2026https://conductscience.org/library/papers/42383990PubMed

1 to 10 of 71

See all 71 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38831455

GET https://conductscience.org/api/papers/v1/38831455/references?page=2

API referenceFor AI assistants